Emerging Biomarker Tests May Expand Options for Autism Identification

For families seeking autism identification for their child, the process can involve long waitlists and relies heavily on clinical observation. Several research teams are developing objective biomarker tests—biological measurements that may indicate autism—that could make screening more accessible. Experts emphasize these tools are meant to supplement, not replace, current diagnostic methods.

Eye-Tracking Shows Potential

One approach uses eye-tracking technology to measure how infants engage with social stimuli. A 2024 study in JAMA Network Open found this method could differentiate autistic children as young as 16 months during pediatric visits by analyzing gaze patterns. As Contemporary Pediatrics noted, this could expand screening access.

A 2024 study in JAMA Network Open found this method could differentiate autistic children as young as 16 months during pediatric visits by analyzing gaze patterns.

Gut Microbiome Research

Another approach examines gut bacteria signatures. Researchers at the Chinese University of Hong Kong developed a stool test with high accuracy in identifying low-probability cases (over 95% negative predictive value in initial studies), as MobiHealthNews reported. Currently piloted with 200 free tests in Hong Kong per CUHK, independent validation is needed.

Digital Approaches

Behavioral analysis through smartphone apps shows potential, with a 2023 Nature study demonstrating machine learning could detect autism-related patterns in home videos. Urinary metabolite tests may also help identify biological subtypes, according to Frontiers in Neuroscience.

Why Identification Matters

Earlier recognition opens doors to support services during developmental windows. As PMC notes, timely accommodations can build communication and coping skills. Autistic adults emphasize that diagnosis at any age brings self-understanding and community connection, not just childhood intervention.